Expenditure analysis of two year payer costs of commercially insured type 2 diabetes patients identified as receiving multiple daily injections (MDI) or insulin pump therapy (CSII) stratified by related diagnosis
Abstract
Authors
C. Zhu J.A. Sierra M. Gill